The multifunctional roles of flavonoids against the formation of advanced glycation end products (AGEs) and AGEs-induced harmful effects

被引:60
|
作者
Zhou, Qian [1 ,2 ]
Cheng, Ka-Wing [1 ,4 ]
Xiao, Jianbo [3 ]
Wang, Mingfu [1 ,2 ]
机构
[1] Shenzhen Univ, Inst Adv Study, Shenzhen, Peoples R China
[2] Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China
[3] Jiangsu Univ, Inst Food Safety & Nutr, Zhenjiang, Jiangsu, Peoples R China
[4] Shenzhen Univ, Inst Innovat Dev Food Ind, Shenzhen, Peoples R China
关键词
AGEs; Methylated; methoxylated flavonoid; Flavonoid glycoside; Flavonoid-RCS adduct; RAGE; ALPHA-DICARBONYL COMPOUNDS; ALDOSE REDUCTASE; IN-VITRO; INHIBITORY-ACTIVITY; DIETARY FLAVONOIDS; TRAPPING METHYLGLYOXAL; ARTEMISIA-CAPILLARIS; DIABETIC-NEPHROPATHY; PROTEIN GLYCATION; POLYPHENOLS;
D O I
10.1016/j.tifs.2020.06.002
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Background: Advanced glycation end products (AGEs) play a crucial role in the onset, progression, and propagation of both macroangiopathy and microangiopathy complications associated with diabetes mellitus, while some dietary flavonoids and their derivatives were proved to be potential in the controlling of AGEs during the past decades. Scope and approach: In this review, the multifunctional effects of flavonoids were summarized in the aspect of inhibiting the formation of AGEs and attenuating AGEs-induced harmful effects. Key findings and conclusions: A multitude of plant-derived flavonoids have been examined of their antiglycative capability in in vitro models, while glycosylation and methylation/methoxylation of flavonoids might decrease the ability of aglycones. Furthermore, the attenuation of AGEs-induced damages by flavonoids were mainly targeted on the receptor of AGEs (RAGE) and through the prevention of MAPKs/NF-kappa B or TGF-beta 1 signaling pathway. Besides, during the inhibition of AGEs formation, flavonoids can trap reactive di-carbonyl species (RCS) and form new adducts. Some of these flavonoid-RCS adducts were further proved to possess bioactivities in foods and biological systems.
引用
收藏
页码:333 / 347
页数:15
相关论文
共 50 条
  • [31] Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications
    Yamagishi, Sho-ichi
    Nakamura, Kazuo
    Imaizumi, Tsutomu
    CURRENT DIABETES REVIEWS, 2005, 1 (01) : 93 - 106
  • [32] Modulation of Inflammasome Signaling by Advanced Glycation End Products (AGEs)
    Son, SeungHwan
    Hwang, Inhwa
    Yu, Je-Wook
    FASEB JOURNAL, 2017, 31
  • [33] Advanced glycation end products (AGEs) activate mast cells
    Sick, E.
    Brehin, S.
    Andre, P.
    Coupin, G.
    Landry, Y.
    Takeda, K.
    Gies, J. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (02) : 442 - 455
  • [34] Advanced glycation end products (AGEs) and their involvement in liver disease
    Hyogo, Hideyuki
    Yamagishi, Sho-ichi
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (10) : 969 - 972
  • [35] Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs)
    Kim, Jong Min
    Lee, Yun Mi
    Lee, Ga Young
    Jang, Dae Sik
    Bae, Ki Hwan
    Kim, Jin Sook
    ARCHIVES OF PHARMACAL RESEARCH, 2006, 29 (10) : 821 - 825
  • [36] Constituents of the roots ofPueraria lobata inhibit formation of advanced glycation end products (AGEs)
    Jong Min Kim
    Yun Mi Lee
    Ga Young Lee
    Dae Sik Jang
    Ki Hwan Bae
    Jin Sook Kim
    Archives of Pharmacal Research, 2006, 29 : 821 - 825
  • [37] Attenuation of Glucose-Induced Myoglobin Glycation and the Formation of Advanced Glycation End Products (AGEs) by (R)-α-Lipoic Acid In Vitro
    Ghelani, Hardik
    Razmovski-Naumovski, Valentina
    Pragada, Rajeswara Rao
    Nammi, Srinivas
    BIOMOLECULES, 2018, 8 (01):
  • [38] Role of profilin-1 in vasculopathy induced by advanced glycation end products (AGEs)
    Xie, Qiying
    Ma, Liping
    Xiao, Zhilin
    Yang, Mei
    Chen, Meifang
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (05)
  • [39] Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs
    Deluyker, Dorien
    Evens, Lize
    Bito, Virginie
    AMINO ACIDS, 2017, 49 (09) : 1535 - 1541
  • [40] Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs
    Dorien Deluyker
    Lize Evens
    Virginie Bito
    Amino Acids, 2017, 49 : 1535 - 1541